Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SPCX
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Plug Power
PLUG
$3.06B
| $20.9M | ﹤0.01% |
7,697,993
+1,978,572
| +35% | +$6.22M |
|
3052
U-Haul Holding Co Series N
UHAL.B
$11.7B
| $20.9M | ﹤0.01% |
361,408
+26,815
| +8% | +$1.34M |
|
|
CHI
3053
Calamos Convertible Opportunities and Income Fund
CHI
$1.04B
| $20.8M | ﹤0.01% |
1,551,031
+137,555
| +10% | +$1.7M |
|
3054
State Street SPDR S&P Pharmaceuticals ETF
XPH
$549M
| $20.8M | ﹤0.01% |
314,226
+26,638
| +9% | +$1.56M |
|
3055
Cadre Holdings
CDRE
$1.32B
| $20.8M | ﹤0.01% |
729,641
-22,155
| -3% | -$668K |
|
|
STK
3056
Columbia Seligman Premium Technology Growth Fund
STK
$928M
| $20.8M | ﹤0.01% |
385,444
+73,904
| +24% | +$3.67M |
|
|
BELFB
3057
Bel Fuse Inc Class B
BELFB
$3.59B
| $20.7M | ﹤0.01% |
62,302
+1,050
| +2% | +$284K |
|
3058
Iovance Biotherapeutics
IOVA
$3.63B
| $20.7M | ﹤0.01% |
4,986,461
-1,214,821
| -20% | -$4.62M |
|
3059
PagSeguro Digital
PAGS
$2.45B
| $20.7M | ﹤0.01% |
2,291,080
-87,834
| -4% | -$849K |
|
3060
iShares MSCI Singapore ETF
EWS
$1.23B
| $20.7M | ﹤0.01% |
699,643
-39,067
| -5% | -$1.14M |
|
3061
Surgery Partners
SGRY
$1.79B
| $20.7M | ﹤0.01% |
1,232,751
+220,574
| +22% | +$3.1M |
|
3062
Albany International
AIN
$1.66B
| $20.7M | ﹤0.01% |
277,552
-35,587
| -11% | -$2.23M |
|
3063
Upwork
UPWK
$1.13B
| $20.6M | ﹤0.01% |
2,463,966
+1,278,271
| +108% | +$12.1M |
|
|
ORLA
3064
DELISTED
Orla Mining
ORLA
| $20.5M | ﹤0.01% |
2,094,418
+1,092,798
| +109% | +$14.5M |
|
3065
Interface
TILE
$2.23B
| $20.5M | ﹤0.01% |
572,097
-120,760
| -17% | -$3.53M |
|
3066
BlackRock Enhanced Captial and Income Fund
CII
$1.01B
| $20.5M | ﹤0.01% |
783,330
+7,188
| +0.9% | +$174K |
|
3067
Invesco Financial Preferred ETF
PGF
$660M
| $20.5M | ﹤0.01% |
1,492,566
-47,444
| -3% | -$660K |
|
3068
Wolverine World Wide
WWW
$1.67B
| $20.4M | ﹤0.01% |
1,236,129
-301,778
| -20% | -$5.1M |
|
3069
VictoryShares US 500 Enhanced Volatility Wtd ETF
CFO
$419M
| $20.4M | ﹤0.01% |
254,694
-1,918
| -0.7% | -$149K |
|
3070
Kemper
KMPR
$1.65B
| $20.4M | ﹤0.01% |
756,307
+28,225
| +4% | +$822K |
|
|
HPP
3071
Hudson Pacific Properties
HPP
$713M
| $20.4M | ﹤0.01% |
1,342,103
+897,238
| +202% | +$9.84M |
|
3072
iShares MSCI Israel ETF
EIS
$900M
| $20.3M | ﹤0.01% |
167,882
+23,386
| +16% | +$2.99M |
|
3073
NBT Bancorp
NBTB
$2.68B
| $20.3M | ﹤0.01% |
410,346
-33,252
| -7% | -$1.52M |
|
3074
AtaiBeckley Inc
ATAI
$2.7B
| $20.3M | ﹤0.01% |
3,843,253
-9,519
| -0.2% | -$40.1K |
|
3075
Schrodinger
SDGR
$1.47B
| $20.2M | ﹤0.01% |
1,245,015
-126,184
| -9% | -$1.69M |
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 423 new, 3,809 increased, 3,216 reduced and 305 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 423 new positions and closed 305 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.